Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02955121 · ClinicalTrials.gov registry record · NA
IU Health Krannert Personalized Medicine Study
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT02955121 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 107 participants.
The verdict
NCT02955121, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
Randomized controlled study to examine physician use of pharmacogenetic information in patients receiving antiplatelet medication after percutaneous coronary intervention (PCI).
Interventions
- OTHER Prescriber Access to Genetic Information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02955121
The ClinicalTrials.gov registry entry for NCT02955121 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prescriber Access to Genetic Information is the first listed.
NCT02955121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02955121 about?
NCT02955121 is a clinical study titled "IU Health Krannert Personalized Medicine Study". Randomized controlled study to examine physician use of pharmacogenetic information in patients receiving antiplatelet medication after percutaneous coronary intervention (PCI).
What is the current status of trial NCT02955121?
This trial is currently terminated. It is a NA study. The enrollment target is 107 participants. The study started on 2016-11. Estimated completion is 2020-01-15.
What interventions are being tested in trial NCT02955121?
The interventions under investigation include: Prescriber Access to Genetic Information (OTHER).
Who is sponsoring clinical trial NCT02955121?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.